Citation Impact
Citing Papers
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Spheroid Culture for Enhanced Differentiation of Human Embryonic Stem Cells to Hepatocyte-Like Cells
2013
Three-Dimensional Scaffolds for Tissue Engineering Applications: Role of Porosity and Pore Size
2013 Standout
Functional Behavior of Primary Rat Liver Cells in a Three-Dimensional Perfused Microarray Bioreactor
2002
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus
2000
Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections
2014
The third dimension bridges the gap between cell culture and live tissue
2007 Standout
Hepatocyte adhesion, growth and differentiated function on RGD-containing proteins
2000
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Physicochemical and Physiological Mechanisms for the Effects of Food on Drug Absorption: The Role of Lipids and pH
1997
Antimicrobial Dosing Considerations in Obese Adult Patients
2007
Hydrogels in Regenerative Medicine
2009 Standout
Adverse Drug Reactions to Systemic Antifungals Prevention and Management
1992
Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
2009
Antibacterial Dosing in Intensive Care
2006
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Long-term culture and expansion of primary human hepatocytes
2015
Drotrecogin Alfa (Activated) in Adults with Septic Shock
2012 Standout
Oral Anticoagulant Therapy
2012 Standout
Drug Interactions with Fluconazole
1990
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Canine Intestinal Contents vs. Simulated Media for the Assessment of Solubility of Two Weak Bases in the Human Small Intestinal Contents
2006
Review: Hydrogels for cell immobilization
2000
Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole
1997
Antimicrobial Therapy in Critically Ill Patients
2005
Antibiotic resistance of bacterial biofilms
2010 Standout
A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems
2017 Standout
Meta-DiSc: a software for meta-analysis of test accuracy data
2006 Standout
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Prolonged engraftment of human hepatocytes in mice transgenic for the deleted form of human hepatocyte growth factor
2007
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs
1998 Standout
Induction of hepatic differentiation in embryonic stem cells by co-culture with embryonic cardiac mesoderm
2003 StandoutNobel
Bioreactor Developments for Tissue Engineering Applications by the Example of the Bioartificial Liver
2002
Human recombinant activated protein C for severe sepsis
2012
SURVIVAL, PROLIFERATION, AND FUNCTIONS OF PORCINE HEPATOCYTES ENCAPSULATED IN COATED ALGINATE BEADS: A STEP TOWARD A RELIABLE BIOARTIFICIAL LIVER1
1997
RGD modified polymers: biomaterials for stimulated cell adhesion and beyond
2003 Standout
Clinical Pharmacokinetics of Ketoconazole
1988
Mini-series: I. Basic science. Uncertainty and inaccuracy of predicting CYP-mediated in vivo drug interactions in the ICU from in vitro models: focus on CYP3A4
2009
In vitro–in vivo correlation: Perspectives on model development
2011
Enzymatic hydroxylation of aromatic compounds
2007
Effect of a Cola Beverage on the Bioavailability of Itraconazole in the Presence of H2 Blockers
1997
Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering
2005 Standout
Cystic fibrosis: A review of pulmonary infections and interventions
1987
Making sense of implementation theories, models and frameworks
2015 Standout
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
Capturing complex 3D tissue physiology in vitro
2006 Standout
The Obese Patient in the ICU
1998
Technology of mammalian cell encapsulation
2000
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Ketoconazole to Reduce the Need for Cyclosporine after Cardiac Transplantation
1995
Reduction of Sputum Pseudomonas aeruginosa Density by Antibiotics Improves Lung Function in Cystic Fibrosis More than Do Bronchodilators and Chest Physiotherapy Alone
1990
Electrospinning: A fascinating fiber fabrication technique
2010 Standout
Untapped potential: exploiting fungi in bioremediation of hazardous chemicals
2011 Standout
Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte Transplantation
1998 Standout
Pharmacokinetic issues for antibiotics in the critically ill patient
2009
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Instrumentation issues in implementation science
2014
Topographic diversity of fungal and bacterial communities in human skin
2013 StandoutNature
HEPATOCYTE TRANSPLANTATION AS A BRIDGE TO ORTHOTOPIC LIVER TRANSPLANTATION IN TERMINAL LIVER FAILURE
1997
Implementing selective digestive tract decontamination in the intensive care unit: A qualitative analysis of nurse-identified considerations
2013
Perioperative antibiotic prophylaxis in the gastric bypass patient: Do we achieve therapeutic levels?
2004
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
DLS and zeta potential – What they are and what they are not?
2016 Standout
Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells
2016 StandoutNobel
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Hepatic Drug Metabolism in Critical Illness
1998
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Comparison of Five In Vitro Digestion Models To Study the Bioaccessibility of Soil Contaminants
2002 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Dialysis Dose and Intradialytic Hypotension: Results from the HEMO Study
2013 Standout
Cell and tissue engineering for liver disease
2014
Hydrogels for Tissue Engineering
2001 Standout
In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease
2017 StandoutNobel
Broadly neutralizing antibodies abrogate established hepatitis C virus infection
2014 StandoutNobel
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Urea, sodium, and water changes in profiling dialysis
1996
Biomaterials in Tissue Engineering
1995
In Vitro Expansion of Human Hepatocytes is Restricted by Telomere-Dependent Replicative Aging
2003
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Biomaterials & scaffolds for tissue engineering
2011 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Drug Disposition in Obese Humans
1986
Host response to tissue engineered devices
1998
Third-Generation Biomedical Materials
2002 StandoutScience
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris®) for the treatment of severe sepsis in adults: a systematic review and economic evaluation
2005
Hydrogels in drug delivery: Progress and challenges
2008 Standout
Works of Henry J. Mann being referenced
Drug-Associated Disease: Cytochrome P450 Interactions
2006
Extended liver-specific functions of porcine hepatocyte spheroids entrapped in collagen gel
1995
A TECHNIQUE FOR PORCINE HEPATOCYTE HARVEST AND DESCRIPTION OF DIFFERENTIATED METABOLIC FUNCTIONS IN STATIC CULTURE
1995
Current Issues Regarding the Use of Drotrecogin alfa (activated)
2002
The science of implementation: changing the practice of critical care
2008
Increased dosage requirements of tobramycin and gentamicin for treating Pseudomonas pneumonia in patients with cystic fibrosis
1985
Hollow fiber bioartificial liver utilizing collagen‐entrapped porcine hepatocyte spheroids
1996
In vitro Characterization of Oritavancin Clearance from Human Blood by Low-Flux, High-Flux, and Continuous Renal Replacement Therapy Dialyzers
2011
Protein C in critical illness
2009
Effect of pH on Disintegration and Dissolution of Ketoconazole Tablets
1983
Extracorporeal Application of a Gel-Entrapment, Bioartificial Liver: Demonstration of Drug Metabolism and Other Biochemical Functions
1993
Cefamandole Distribution in Serum, Adipose Tissue, and Wound Drainage in Morbidly Obese Patients
1986
Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver.
1994
Decreased hepatic clearance of clindamycin in critically ill patients with sepsis.
1987
Pharmacokinetics and pharmacodynamics in critically ill patients
1987
Intrapatient variation of aminoglycoside pharmacokinetics in critically ill surgery patients.
1988
Influence of obesity on drug disposition.
1987
Tobramycin pharmacokinetics in morbidly obese patients
1979
The Donnan effect in artificial kidney therapy.
1987
Appraisal of four novel approaches to the prevention and treatment of sepsis
2004
Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis.
1987
Recombinant human activated protein C in severe sepsis
2002